| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.091 | 0.05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.092 | 0.06 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.078 | 0.09 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.069 | 0.2 |